Washington, Apr 1 (ANI): A potential new HIV drug may one day treat patients who are not responding to Anti-Retroviral Therapy, suggests a new study.
Researchers, from Imperial College London, the National Cancer Institute, Bethesda, and Innsbruck Medical University, said when they used a molecule called D-1mT alongside Anti-Retroviral Therapy (ART) to treat monkeys they were able to reduce the levels of the simian form of ...
Full story